相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Christos Hatzis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer
Nicholas J. Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
David W. Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
Jan P. A. Baak et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma
Femke Hillen et al.
MELANOMA RESEARCH (2006)
Vascular proliferation is important for clinical progress of endometrial cancer
IM Stefansson et al.
CANCER RESEARCH (2006)
Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years
JPA Baak et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer
JB Arnes et al.
CLINICAL CANCER RESEARCH (2005)
Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis
S Sharma et al.
HISTOPATHOLOGY (2005)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
Prognostic value of proliferation in invasive breast cancer: a review
PJ van Diest et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Microvessel density as a prognostic factor in women with breast cancer: A systematic review of the literature and meta-analysis
B Uzzan et al.
CANCER RESEARCH (2004)
Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
JR Goffin et al.
BRITISH JOURNAL OF CANCER (2003)
Prognostic factors in breast cancer: Current and new predictors of metastasis
DF Hayes et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2001)
Clinical significance of determination of surrogate markers of angiogenesis in breast cancer
G Gasparini
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
分享论文
